We are pleased to present the first in a series of webinars relating to Goodwin’s Guide to Biosimilars Litigation and Regulation in the U.S. which provides expert guidance and practical know-how for lawyers working in this growing area of the law.
The first webinar, So You Want To Make A Biosimilar? Top Considerations Before You Start, will take place tomorrow, Wednesday, April 8th. Big Molecule Watch editors Mike Cottler, Cindy Chang and Keith Zullow will provide a broad overview of important strategic considerations that biosimilar makers should take into account before applying for an aBLA to increase their odds of a successful approval and launch.
Visit this page to register for future webinars in this series.